• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM S.R.L. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM S.R.L. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVF-S
Device Problem Leak/Splash (1354)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 08/22/2022
Event Type  Injury  
Event Description
On (b)(6) 2022, a perceval plus sutureless aortic heart valve pvf-s was implanted.After the implantation of this perceval plus valve, there was residual ar.Based on the 2d echocardiography report, aortic root diameter, left ventricle ed and es dimension, ivs es, left ventricular pw(ed and es) was within the normal value range (3.1, 4.7 and 3.3, 1.5, 0.9 and 1.1, respectively).Left atrial dimension and ivs ed was little bit out of the ravage of normal value (4.2 and 1.3, respectively).2d imaging in plax, sax and apical views revealed concentric lvh & normal lv systolic function.Movement of the septum, anterior, inferior posterior and lateral walls are normal.Lvef is 55%.Mitral valve opening is normal.No evidence of mitral valve prolapse is seen.Mildly dilated la with no apparent la / laa clot seen.Avd; aortic valve thickened & calcified with severe calcific as (ava 0.41sqcm by continuity equation, sv 34ml, dvi 0.16, mpg 42mmhg, max pg 68mmhg, max velocity 412cm/sec) with mild ar, aortic annulus 20.5mm.Tricuspid valve leaflets move normally.Pulmonary valve is normal.Interatrial and interventricular septum are intact.No intracardiac mass or thrombus is seen.No pericardial pathology is observed.
 
Manufacturer Narrative
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.A follow up report will be provided upon receipt of the device or further information.
 
Manufacturer Narrative
Updated fields: b4, b5, g3, g6, h2, h6.
 
Event Description
On (b)(6) 2022, a perceval plus sutureless aortic heart valve pvf-s was implanted in a patient with severe calcified aortic stenosis.Based on the 2d echocardiography report, aortic root diameter, left ventricle ed and es dimension, ivs es, left ventricular pw(ed and es) was within the normal value range (3.1, 4.7 and 3.3, 1.5, 0.9 and 1.1, respectively).Left atrial dimension and ivs ed was little bit out of the ravage of normal value (4.2 and 1.3, respectively).2d imaging in plax, sax and apical views revealed concentric lvh & normal lv systolic function.Movement of the septum, anterior, inferior posterior and lateral walls are normal.Lvef is 55%.Mitral valve opening is normal.No evidence of mitral valve prolapse is seen.Mildly dilated la with no apparent la / laa clot seen.Avd; aortic valve thickened & calcified with severe calcific as (ava 0.41sqcm by continuity equation, sv 34ml, dvi 0.16, mpg 42mmhg, max pg 68mmhg, max velocity 412cm/sec) with mild ar, aortic annulus 20.5mm.Tricuspid valve leaflets move normally.Pulmonary valve is normal.Interatrial and interventricular septum are intact.No intracardiac mass or thrombus is seen.No pericardial pathology is observed.Based on the additional information received, while weaning off cpb, severe central ar with lv distension was noted.As such, the valve was explanted, a 19 mm mechanical valve was implanted, and patient was discharged in stable condition.As reported, the wound of the aorta was very horizontal.Based on the medical judgement received, the valve may got distorted because of the acute aortic angle between lv and aortic annulus.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM S.R.L.
strada crescentino
saluggia, vercelli
Manufacturer (Section G)
CORCYM S.R.L.
strada crescentino
saluggia, vercelli
Manufacturer Contact
roberta lamberti
5005 north fraser way
burnaby, bc 
MDR Report Key15447364
MDR Text Key300161127
Report Number3005687633-2022-00139
Device Sequence Number1
Product Code LWR
UDI-Device Identifier08022057015365
UDI-Public(01)08022057015365(240)PVF-S(17)260221
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011/S013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/19/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVF-S
Device Catalogue NumberPVF-S
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received09/19/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
Patient SexFemale
-
-